how much of what we believe about Apotheke actually comes from pharmacy threads
how much of what we believe about Apotheke actually comes from pharmacy threads. If this has been answered properly somewhere, link me and I will delete.
On cross-border prescriptions, since the assumption behind half these threads is wrong.
There are EU rules on the recognition of prescriptions issued in another member state, and they are conditional: the prescription has to meet requirements about its form and content, certain categories are excluded, and pharmacies retain discretion in practice.
The result is that "my prescription will be accepted anywhere in the EU" is not a safe assumption, and members here have discovered it at a counter in another country. If it matters for a trip, check before you travel with the pharmacy and with somebody qualified where you are. Nothing on this board is advice about that, and the rules are national in their application whatever the framework says.
Asked in my own language at a local pharmacy and got a clearer answer in five minutes than a fortnight of forum reading.
The structure that makes this board make sense, once.
Marketing authorisation for these products is granted centrally, which is why the same product exists across the union. Everything after that — whether it is reimbursed, on what criteria, at what price, in what pack size, dispensed under what margin rules — is decided nationally.
So "is it covered" has twenty-seven answers, "what does it cost" has twenty-seven answers plus within-country variation, and only "is it authorised" has one. Almost every argument on this board is two people answering different questions from different countries, both correctly.
Sceptical readings welcome. The confident ones are the ones I distrust.
best — the order this archive was captured in
Published reimbursement criteria exist in most member states and are usually available in the national language. They are the authoritative answer to eligibility questions that this board can only guess at.
[deleted]
Small fix — those two prices are for different pack sizes, which accounts for most of the gap.
Correcting myself upthread: the criterion I quoted was updated for this year.
What does the local patient information leaflet say?
Left up. It names the member state and the pack size, which is all we ask of a pricing post.
the EMA authorises, member states decide who pays
the EMA authorises, member states decide who pays
This is the split the whole board depends on. Authorisation is European; payment is national.
This is the split the whole board depends on.
renal_outcomes_r is right about cross-border recognition being narrower than the summaries suggest.
ask for the Beipackzettel or the local equivalent, it answers most questions
reimbursement is national, not European, and that is the whole board
Agreed that pharmacy margin regulation explains a lot of the price differences people find mysterious.
This. The published reimbursement criteria are the document to read, and most member states do publish them.
the language barrier is a real cost and nobody budgets for it
The variation between pharmacies inside my own country was larger than the variation I had been chasing across the border.
Have you read the published reimbursement criteria where you are?
- 1Left up. It names the member state and the pack size, which is all we ask of…11 comments in this branch · started by u/eu_apotheke_a